Association Study of IGF-1 rs35767 and rs6214 Gene Polymorphisms with Cancer Susceptibility and Circulating Levels of IGF-1, IGFBP-2, and IGFBP-3 in Colorectal Cancer Patients

Early detection of colorectal cancer (CRC) increases the 5-year survival rate by 90%; therefore, non-invasive biomarkers such as measurable circulating proteins for early detection and prognosis are crucial. Insulin-like growth factor-1 (IGF-1) is involved in the regulation of cell proliferation and...

Full description

Bibliographic Details
Main Authors: Maryam H. Alrashid, Ahmad E. Al-Serri, Rubina F. Hussain, Suzanne A. Al-Bustan, Jasem Al-Barrak
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/12/3166
_version_ 1797381965609959424
author Maryam H. Alrashid
Ahmad E. Al-Serri
Rubina F. Hussain
Suzanne A. Al-Bustan
Jasem Al-Barrak
author_facet Maryam H. Alrashid
Ahmad E. Al-Serri
Rubina F. Hussain
Suzanne A. Al-Bustan
Jasem Al-Barrak
author_sort Maryam H. Alrashid
collection DOAJ
description Early detection of colorectal cancer (CRC) increases the 5-year survival rate by 90%; therefore, non-invasive biomarkers such as measurable circulating proteins for early detection and prognosis are crucial. Insulin-like growth factor-1 (IGF-1) is involved in the regulation of cell proliferation and apoptosis. IGF binding proteins (IGFBPs) bind and inhibit the activity of IGF-1. It was inconsistently reported that high IGF-1 and IGFBP-2 and low IGFBP-3 circulating levels are associated with high cancer risk, poor prognosis, and tumor metastasis in several cancers. A total of 175 patients with CRC and 429 controls were enrolled in this study. We genotyped for IGF-1 rs35767 and rs6214 gene polymorphisms and assessed their association with circulating levels of IGF-1 and/or the risk for CRC. We also determined plasma levels of IGF-1, IGFBP-2, and IGFBP-3. Neither rs35767 nor rs2614 were associated with cancer risk or IGF-1 levels in our study cohort. IGF-1 and IGFBP-3 levels were higher in controls than in patients, whereas IGFBP-2 was higher in patients than in controls. Only IGFBP-2 was associated with increased tumor grade but not stage. Therefore, IGF-1, IGFBP-2, and IGFBP-3 may be useful as early detection and prognostic biomarkers in CRC.
first_indexed 2024-03-08T20:58:40Z
format Article
id doaj.art-6cb2011d09294b82a89791d80056d37e
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-08T20:58:40Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-6cb2011d09294b82a89791d80056d37e2023-12-22T13:54:51ZengMDPI AGBiomedicines2227-90592023-11-011112316610.3390/biomedicines11123166Association Study of IGF-1 rs35767 and rs6214 Gene Polymorphisms with Cancer Susceptibility and Circulating Levels of IGF-1, IGFBP-2, and IGFBP-3 in Colorectal Cancer PatientsMaryam H. Alrashid0Ahmad E. Al-Serri1Rubina F. Hussain2Suzanne A. Al-Bustan3Jasem Al-Barrak4Department of Biological Sciences, Faculty of Science, Kuwait University, Safat, Kuwait City 13060, KuwaitHuman Genetics Unit, Department of Pathology, Faculty of Medicine, Kuwait University, Safat, Kuwait City 13060, KuwaitDepartment of Biological Sciences, Faculty of Science, Kuwait University, Safat, Kuwait City 13060, KuwaitDepartment of Biological Sciences, Faculty of Science, Kuwait University, Safat, Kuwait City 13060, KuwaitKuwait Cancer Control Center, Kuwait City 70030, KuwaitEarly detection of colorectal cancer (CRC) increases the 5-year survival rate by 90%; therefore, non-invasive biomarkers such as measurable circulating proteins for early detection and prognosis are crucial. Insulin-like growth factor-1 (IGF-1) is involved in the regulation of cell proliferation and apoptosis. IGF binding proteins (IGFBPs) bind and inhibit the activity of IGF-1. It was inconsistently reported that high IGF-1 and IGFBP-2 and low IGFBP-3 circulating levels are associated with high cancer risk, poor prognosis, and tumor metastasis in several cancers. A total of 175 patients with CRC and 429 controls were enrolled in this study. We genotyped for IGF-1 rs35767 and rs6214 gene polymorphisms and assessed their association with circulating levels of IGF-1 and/or the risk for CRC. We also determined plasma levels of IGF-1, IGFBP-2, and IGFBP-3. Neither rs35767 nor rs2614 were associated with cancer risk or IGF-1 levels in our study cohort. IGF-1 and IGFBP-3 levels were higher in controls than in patients, whereas IGFBP-2 was higher in patients than in controls. Only IGFBP-2 was associated with increased tumor grade but not stage. Therefore, IGF-1, IGFBP-2, and IGFBP-3 may be useful as early detection and prognostic biomarkers in CRC.https://www.mdpi.com/2227-9059/11/12/3166insulin-like growth factor-1colorectal cancerbiomarkersgene polymorphism
spellingShingle Maryam H. Alrashid
Ahmad E. Al-Serri
Rubina F. Hussain
Suzanne A. Al-Bustan
Jasem Al-Barrak
Association Study of IGF-1 rs35767 and rs6214 Gene Polymorphisms with Cancer Susceptibility and Circulating Levels of IGF-1, IGFBP-2, and IGFBP-3 in Colorectal Cancer Patients
Biomedicines
insulin-like growth factor-1
colorectal cancer
biomarkers
gene polymorphism
title Association Study of IGF-1 rs35767 and rs6214 Gene Polymorphisms with Cancer Susceptibility and Circulating Levels of IGF-1, IGFBP-2, and IGFBP-3 in Colorectal Cancer Patients
title_full Association Study of IGF-1 rs35767 and rs6214 Gene Polymorphisms with Cancer Susceptibility and Circulating Levels of IGF-1, IGFBP-2, and IGFBP-3 in Colorectal Cancer Patients
title_fullStr Association Study of IGF-1 rs35767 and rs6214 Gene Polymorphisms with Cancer Susceptibility and Circulating Levels of IGF-1, IGFBP-2, and IGFBP-3 in Colorectal Cancer Patients
title_full_unstemmed Association Study of IGF-1 rs35767 and rs6214 Gene Polymorphisms with Cancer Susceptibility and Circulating Levels of IGF-1, IGFBP-2, and IGFBP-3 in Colorectal Cancer Patients
title_short Association Study of IGF-1 rs35767 and rs6214 Gene Polymorphisms with Cancer Susceptibility and Circulating Levels of IGF-1, IGFBP-2, and IGFBP-3 in Colorectal Cancer Patients
title_sort association study of igf 1 rs35767 and rs6214 gene polymorphisms with cancer susceptibility and circulating levels of igf 1 igfbp 2 and igfbp 3 in colorectal cancer patients
topic insulin-like growth factor-1
colorectal cancer
biomarkers
gene polymorphism
url https://www.mdpi.com/2227-9059/11/12/3166
work_keys_str_mv AT maryamhalrashid associationstudyofigf1rs35767andrs6214genepolymorphismswithcancersusceptibilityandcirculatinglevelsofigf1igfbp2andigfbp3incolorectalcancerpatients
AT ahmadealserri associationstudyofigf1rs35767andrs6214genepolymorphismswithcancersusceptibilityandcirculatinglevelsofigf1igfbp2andigfbp3incolorectalcancerpatients
AT rubinafhussain associationstudyofigf1rs35767andrs6214genepolymorphismswithcancersusceptibilityandcirculatinglevelsofigf1igfbp2andigfbp3incolorectalcancerpatients
AT suzanneaalbustan associationstudyofigf1rs35767andrs6214genepolymorphismswithcancersusceptibilityandcirculatinglevelsofigf1igfbp2andigfbp3incolorectalcancerpatients
AT jasemalbarrak associationstudyofigf1rs35767andrs6214genepolymorphismswithcancersusceptibilityandcirculatinglevelsofigf1igfbp2andigfbp3incolorectalcancerpatients